Your browser doesn't support javascript.
loading
Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in China.
Hong, Ye; Song, Mengjia; Lan, Yingxia; Wang, Juan; Lu, Suying; Zhang, Yu; Zhu, Jia; Sun, Feifei; Huang, Junting; Liu, Juan; Xu, Jiaqian; Wu, Yanpeng; Guo, Haixia; Cai, Ruiqing; Zhen, Zijun; Que, Yi; Zhang, Yizhuo.
Afiliação
  • Hong Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Song M; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lan Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang J; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang Y; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhu J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Sun F; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Liu J; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xu J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wu Y; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Guo H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai R; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhen Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Que Y; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Front Immunol ; 14: 1182751, 2023.
Article em En | MEDLINE | ID: mdl-37359533
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article